Organization

Dept. of Dermatology, University Hospital Zürich

2 abstracts

Abstract
Intralesional oncolytic virotherapy with talimogene laherparepvec in patients with cutaneous lymphomas and non-melanoma skin cancers.
Org: Department of Dermatology, University Hospital of Zurich, University Hospital Zurich, University Hospital Zurich - USZ, Dept. of Dermatology, University Hospital Zürich, University of Zurich and University Hospital Zurich,
Abstract
Interim analysis of MelaRisk, a biomarker assay validation study in stage IB/IIA melanoma tissue.
Org: Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany, Tübingen, Germany,